S-22611
-
Technical Data
Description
S-22611 (Epertinib) is a potent, oral, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively; S-22611 (Epertinib) shows potent antitumor activity.